Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug trial for chronic shoulder pain halted early

NCT ID NCT05722522

Summary

This study tested whether a drug called secukinumab, given as an injection, could improve pain and function in adults with persistent, moderate-to-severe shoulder pain from rotator cuff tendinopathy. Participants received either the drug or a placebo injection, along with standard painkillers and physiotherapy, over 16 weeks. The trial was terminated early by the sponsor to focus on other projects, so full results are not available.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TENDINOPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Healthy Life Research

    Miami, Florida, 33184, United States

  • IRIS Research and Development

    Plantation, Florida, 33324, United States

  • Millennium Clinical Trials

    Westlake Village, California, 91361, United States

  • Novartis Investigative Site

    San Miguel Tucuman, Tucumán Province, 4000, Argentina

  • Novartis Investigative Site

    Buenos Aires, C1114AAP, Argentina

  • Novartis Investigative Site

    San Miguel de Tucumán, 4000, Argentina

  • Novartis Investigative Site

    Sofia, 1336, Bulgaria

  • Novartis Investigative Site

    Québec, Quebec, G1V 3M7, Canada

  • Novartis Investigative Site

    Brno, Czech Republic, 66250, Czechia

  • Novartis Investigative Site

    Kolín, 280 02, Czechia

  • Novartis Investigative Site

    Kota Kinabalu, Sabah, 88300, Malaysia

  • Novartis Investigative Site

    Ponte de Lima, 4990-041, Portugal

  • Precision Clinical Research LLC

    Sunrise, Florida, 33351, United States

  • West Clinical Research

    Morehead City, North Carolina, 28557, United States

  • West Tennessee Research Institute

    Jackson, Tennessee, 38305, United States

Conditions

Explore the condition pages connected to this study.